{"title": "Pfizer Inc., a corporation, and Wyeth, a corporation, In the Matter of", "author": "John Newman; Amy Ritchie; Bureau", "url": "https://www.ftc.gov/legal-library/browse/cases-proceedings/091-0053-pfizer-inc-corporation-wyeth-corporation-matter", "hostname": "ftc.gov", "description": "The Commission challenged Pfizer Inc.'s proposed $68 billion acquisition of Wyeth and required significant divestitures to preserve competition in multiple U.S. markets for animal pharmaceuticals and vaccines. The proposed consent order remedies the anticompetitive effects the Commission believes are likely to result from the transaction in numerous markets for animal vaccines and animal pharmaceutical products. After a thorough investigation, the Commission concluded that the transaction does not raise anticompetitive concerns in any human health product markets.", "sitename": "Federal Trade Commission", "date": "2009-10-14", "cleaned_text": "Case Summary The Commission challenged Pfizer Inc.'s proposed $68 billion acquisition of Wyeth and required significant divestitures to preserve competition in multiple U.S. markets for animal pharmaceuticals and vaccines. The proposed consent order remedies the anticompetitive effects the Commission believes are likely to result from the transaction in numerous markets for animal vaccines and animal pharmaceutical products. After a thorough investigation, the Commission concluded that the transaction does not raise anticompetitive concerns in any human health product markets. "}